value based pricing

What Do Value Assessments Miss? Rethinking Value Using New Health Economics Evidence.

November 11th, 2019|Categories: Blog|Tags: , , , , , , |

Dr. Patti Peeples, CEO and Founder of HealthEconomics.Com, recently sat down with Dr. Anupam Jena, Scientific Advisor, Precision Xtract, to discuss his latest research that expands the definition and measurement of value of novel therapies by using new health economics evidence.

CVS Caremark’s foray into cost-effectiveness analysis raises questions about the future of prescription medicines in America

September 25th, 2018|Categories: Blog, Featured, HEOR Feature, Industry News|Tags: , , , , , , , , , , |

Written By: Americans spend more on prescription drugs than anyone else in the world. In a move to address this, [...]

Go to Top